advertisement
Abstract #13295 Published in IGR 8-1
New pharmacological perspectives of melatonin in the treatment of ocular pathologies
Pintor JAnales de la Real Academia Nacional de Farmacia 2005; 71: 429-438
Melatonin is a neurohorrnone which participates in the control of circadian cycles. This substance presents a new dimension as a drug when it is assayed for the treatment of some ocular pathologies. In particular, the administration of this compound permits to observe a clear and sustained reduction in the intraocular pressure. This is relevant fact since most of the treatments of glaucoma are based on a reduction in the ocular pressure. Another role of melatonin is the acceleration of the corneal wound healing. When topically applied, melatonin can accelerate the rate of re-epithelialisation up to 165%, therefore this compound may be used to facilitate corneal wound healing or as a complementary drug after ocular surgery. LA: Spanish
Classification:
11.15 Other drugs in relation to glaucoma (Part of: 11 Medical treatment)
